Scholars@Duke

Bevacizumab (BV) continuation following BV progression: Meta-analysis of five consecutive recurrent glioblastoma (GBM) trials.

Publication ,  Journal Article
Reardon, DA; Vredenburgh, JJ; Desjardins, A; Peters, K; Coan, AD; Herndon, JE; Friedman, HS
Published in: JOURNAL OF CLINICAL ONCOLOGY
May 20, 2011
Link to item

Duke Scholars

James Emmett Herndon II
Author James Emmett Herndon II Biostatistics & Bioinformatics, Division of Biostatistics
Henry Seth Friedman
Author Henry Seth Friedman Neurosurgery, Neuro-Oncology

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2011

Volume

29

Issue

15

Publisher

AMER SOC CLINICAL ONCOLOGY

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Reardon, D. A., Vredenburgh, J. J., Desjardins, A., Peters, K., Coan, A. D., Herndon, J. E., & Friedman, H. S. (2011). Bevacizumab (BV) continuation following BV progression: Meta-analysis of five consecutive recurrent glioblastoma (GBM) trials. JOURNAL OF CLINICAL ONCOLOGY, 29(15).
Reardon, D. A., J. J. Vredenburgh, A. Desjardins, K. Peters, A. D. Coan, J. E. Herndon, and H. S. Friedman. “Bevacizumab (BV) continuation following BV progression: Meta-analysis of five consecutive recurrent glioblastoma (GBM) trials.” JOURNAL OF CLINICAL ONCOLOGY 29, no. 15 (May 20, 2011).
Reardon DA, Vredenburgh JJ, Desjardins A, Peters K, Coan AD, Herndon JE, et al. Bevacizumab (BV) continuation following BV progression: Meta-analysis of five consecutive recurrent glioblastoma (GBM) trials. JOURNAL OF CLINICAL ONCOLOGY. 2011 May 20;29(15).
Reardon, D. A., et al. “Bevacizumab (BV) continuation following BV progression: Meta-analysis of five consecutive recurrent glioblastoma (GBM) trials.” JOURNAL OF CLINICAL ONCOLOGY, vol. 29, no. 15, AMER SOC CLINICAL ONCOLOGY, May 2011.
Reardon DA, Vredenburgh JJ, Desjardins A, Peters K, Coan AD, Herndon JE, Friedman HS. Bevacizumab (BV) continuation following BV progression: Meta-analysis of five consecutive recurrent glioblastoma (GBM) trials. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2011 May 20;29(15).

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2011

Volume

29

Issue

15

Publisher

AMER SOC CLINICAL ONCOLOGY

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences